Can a lower steroid dose preserve strength in young boys with DMD?
NCT ID NCT05412394
First seen Aug 14, 2026 ยท Last updated Aug 14, 2026
Summary
This trial is testing whether a lower weekly dose of the corticosteroid prednisolone (5 mg/kg per week) can be as effective as the standard higher dose (10 mg/kg per week) in preserving motor function in young boys with Duchenne muscular dystrophy (DMD). The study will enroll boys aged 1 to 30 months who have a confirmed DMD diagnosis and have not yet been treated with glucocorticosteroids. Over 24 months, researchers will measure changes in gross motor skills, as well as language, social, and fine motor development, to see if the lower dose offers a better balance of benefit and side effects.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- prednisolone (a corticosteroid)
- What this could lead to
- If effective, a lower weekly dose of prednisolone could offer a safer, equally effective treatment option for young boys with Duchenne muscular dystrophy, potentially reducing side effects.
- What could go wrong
- This is a small, early-phase trial, and the lower dose may not be as effective as the standard dose. Corticosteroids can have significant side effects, especially in young children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DUCHENNE MUSCULAR DYSTROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Lurie Children's Hospital of Chicago
RECRUITINGChicago, Illinois, 60611, United States
-
Nationwide Children's Hospital
RECRUITINGColumbus, Ohio, 43205, United States
-
University of Cincinnati
RECRUITINGCincinnati, Ohio, 45220, United States
-
University of Texas Southwestern
RECRUITINGDallas, Texas, 75235, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a targeted infusion slow muscle decline in duchenne? a new trial aims to find out.
- Can a massive patient database unlock new treatments for muscular dystrophy?
- Umbilical cord stem cells aim to slow muscle loss in duchenne boys
- Experimental drug aims to preserve arm and lung function in boys with advanced duchenne
- Experimental drug KER-065 aims to slow muscle decline in duchenne muscular dystrophy
- Can early parent coaching help infants with rare genetic disorders thrive?